Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co at Cowen Health Care Conference Transcript

Mar 06, 2023 / 03:30PM GMT
Release Date Price: $4.13 (+0.49%)
Joe Thorne
TD Cowen - Analyst

Alright, everyone. I think we're going to go ahead and get started with the next panel. Welcome everyone to our Genetic Medicines Panel at the 43rd Annual Healthcare Conference. I'm Joe Thorne, one of the senior biotech analysts here on the team at TD Cowen. And I am joined by my colleagues, Phil Nadeau and Tara Bancroft.

And it is our pleasure to have with us today a great panel of representatives. We have CEO, Gilmore O'Neill, from Editas; CEO, Geoff McDonough, from Generation Bio; CEO, Gaurav Shah, from Rocket; CEO, Faraz Ali, from Tenaya; CEO, Matt Kapusta, from uniQure; and CEO, Al Sandrock, from Voyager. So thank you all very much for joining us.

We're going to start the conversation off with a few thematic questions just on the space overall, and then we'll do a little bit run around between the individual companies on their specific programs.

So maybe just broadly, we're obviously seeing a lot more genetic therapies progress through development into the clinic and now, obviously the commercial stage. But many are still in the preclinical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot